Evidence map›Paper›PMID 28137449›Full record

ArticleNeuropharmacology2017

The binding orientations of structurally-related ligands can differ; A cautionary note.

Marc-David Ruepp, Hao Wei, Michele Leuenberger, Martin Lochner, Andrew J Thompson

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Evaluating Biofilm Inhibitory Potential in Fish Pathogen,Antibiotics (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Common binding sites for cholesterol and neurosteroids on a pentameric ligand-gated ion channel.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marc-David RueppDepartment of Chemistry and Biochemistry, University of Bern, Bern, Switzerland.
Hao WeiDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Michele LeuenbergerDepartment of Chemistry and Biochemistry, University of Bern, Bern, Switzerland.
Martin LochnerDepartment of Chemistry and Biochemistry, University of Bern, Bern, Switzerland; Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland. Electronic address: martin.lochner@ibmm.unibe.ch.
Andrew J ThompsonDepartment of Pharmacology, University of Cambridge, Cambridge, UK. Electronic address: ajt44@cam.ac.uk.
University of Bern · CHUniversity of Cambridge · GB

Funding

British Heart Foundation PG/13/39/30293
6 · The paper itself

Abstract

Crystal structures can identify ligand-receptor interactions and assist the development of novel therapeutics, but experimental challenges sometimes necessitate the use of homologous proteins. Tropisetron is an orthosteric ligand at both 5-HT

Indexed as

Models, MolecularBinding, CompetitiveBinding SitesCrystallography, X-RayGranisetronHEK293 CellsHumansIndolesLigandsMolecular StructureMutationReceptors, Serotonin, 5-HT3Serotonin AntagonistsStructure-Activity RelationshipTritiumTropisetronGranisetronIndolesLigandsReceptors, Serotonin, 5-HT3Serotonin AntagonistsTritiumTropisetron5-HT(3)AgonistAntagonistBindingCrystalCys-loopGranisetronIon channelLigandRadioligandReceptorStructureSynthesisTropisetron

Identifiers

PMID28137449
PMCPMC5464333
OpenAlexW2583065898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.